Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia

Somatic mutation of the DNMT3A gene at the arginine R882 site is common in acute myeloid leukaemia (AML). The prognostic significance of DNMT3A R882 mutation clearance, using traditional diagnostic next generation sequencing (NGS) methods, during complete remission (CR) in AML patients is controvers...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Haematol
Päätekijät: Bhatnagar, Bhavana, Eisfeld, Ann-Kathrin, Nicolet, Deedra, Mrózek, Krzysztof, Blachly, James S., Orwick, Shelley, Lucas, David M., Kohlschmidt, Jessica, Blum, William, Kolitz, Jonathan E., Stone, Richard M., Bloomfield, Clara D., Byrd, John C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063708/
https://ncbi.nlm.nih.gov/pubmed/27476855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.14254
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia